Evidence map›Paper›PMID 42870883›Full record

ArticleTranslational cancer research2026

Integrating multimodal data for precise subtyping and prognostication in patients with pulmonary mucinous adenocarcinoma.

Weiwei Yang, Chen Chen, Lue Li, Zehao Chen, Ziyi Chen, Hanbo Le, Yongkui Zhang, Wangyu Zhu

Abstract read
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Weiwei YangCell and Molecular Biology Laboratory, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China.ORCID https://orcid.org/0009-0007-0826-8262
Chen ChenLung Cancer Research Centre, Zhoushan Hospital, Zhoushan, China.
Lue LiDepartment of Respiratory and Critical Care, Zhoushan Hospital, Zhoushan, China.ORCID https://orcid.org/0009-0001-5965-6229
Zehao ChenCell and Molecular Biology Laboratory, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China.ORCID https://orcid.org/0009-0005-7990-3230
Ziyi ChenCell and Molecular Biology Laboratory, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China.ORCID https://orcid.org/0009-0009-1956-9858
Hanbo LeLung Cancer Research Centre, Zhoushan Hospital, Zhoushan, China.ORCID https://orcid.org/0000-0001-7738-5277
Yongkui ZhangLung Cancer Research Centre, Zhoushan Hospital, Zhoushan, China.
Wangyu ZhuCell and Molecular Biology Laboratory, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China.ORCID https://orcid.org/0000-0003-4805-0800

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulmonary mucinous adenocarcinoma (PMA) represents a rare lung adenocarcinoma subtype, characterized by a lack of comprehensive pathological classification and prognostic factors. In this study, we propose a multimodal machine learning (ML) framework that integrates multiple data modalities to enhance PMA subtype classification and prognostic prediction. Methods: This retrospective study enrolled 175 primary PMA cases with details of demographic, histopathological, computed tomography (CT) imaging, and epithelial growth factor receptor ( Results: Pure mucinous adenocarcinoma presented a higher prevalence of smaller radiographic or pathological tumor size, lower lobe localization, lower rates of lymph node metastasis and spread through air spaces (STAS), early pathological stage, carcinoembryonic antigen (CEA) ≤5 ng/mL, spiculated margin, Ki-67 low expression and lower frequency of Conclusions: Pulmonary pure mucinous adenocarcinoma exhibited lower malignancy compared to the mixed mucinous and mucin-secreting type. The nomogram model developed and validated in this study exhibited promising efficacy in predicting histological subtype preoperatively and survival in patients with PMA, offering guidance for clinicians in diagnosis and prognosis prediction.

Indexed as

Histological characteristicsmachine learning (ML)nomogramprognosispulmonary mucinous adenocarcinoma (PMA)

Identifiers

PMID42870883
PMCPMC13657839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.